China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- China's defense ministry calls for united efforts to contain Japan's militarism revival
- Qinghai-Xizang Railway sets passenger record during 14th FYP period
- China-UAE joint air force training enhances practical cooperation
- Japan's offensive space policy is extremely dangerous: spokesman
- New beetle discovered in Potala Palace structures
- Investigators dismantle 200 professional criminal gangs, uncovering $4b illegal funds
